PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
180.25K
Worse than BTAI's estimated revenue of 1.71M.
-36.05K
Better than BTAI's estimated ebitda of -342.97K.
-2.06
Better than BTAI's estimated eps of -94.44.
-62.22M
Better than BTAI's estimated net income of -242.13M.
-36.05K
Better than BTAI's estimated ebit of -342.97K.
6.68M
Better than BTAI's estimated sg&a expense of 89.53M.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
-50.53%
Worse than BTAI's revenue growth rate of 41.05%.
No Data
No DCF data available for this metric in the selected year.
-20.00%
Equal to BTAI's ebitda margin of -20.00%.
No Data
No DCF data available for this metric in the selected year.
-20.00%
Equal to BTAI's ebit margin of -20.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to BTAI's cash as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
40.00%
Better than BTAI's receivables as percentage of revenue of 55.41%.
No Data
No DCF data available for this metric in the selected year.
40.00%
Better than BTAI's inventories as percentage of revenue of 85.99%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to BTAI's payables as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
-29.43%
Better than BTAI's capex as percentage of revenue of -7.70%.
4.99%
Better than BTAI's weighted average cost of capital (wacc) of 14.35%.
5.02%
Worse than BTAI's cost of equity of 5.00%.
4.08%
Better than BTAI's cost of debt of 14.70%.
-0.23
Better than BTAI's beta of 0.08.
30.07M
Worse than BTAI's diluted shares outstanding of 2.54M.
1.57M
Better than BTAI's total debt of 102.95M.
49.31M
Better than BTAI's total equity of 3.68M.
50.89M
Worse than BTAI's total capital of 106.62M.
3.09%
Better than BTAI's debt weighting of 96.55%.
96.91%
Better than BTAI's equity weighting of 3.45%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
2.00%
Equal to BTAI's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than BTAI's net debt of 73.09M.
71.33M
Better than BTAI's equity value of -68.24M.
2.37
Better than BTAI's equity value per share of -26.92.